Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/bcnu or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation - a registry study on behalf of the EBMT Acute Leukemia Working Party
Afonso, J. D. Finke, J. Ngoya, M. Galimard, J. E. Craddock, C. Raj, K. Bloor, Adrian Nicholson, E. Eder, M. Orchard, K. H.
Afonso, J. D.
Finke, J.
Ngoya, M.
Galimard, J. E.
Craddock, C.
Raj, K.
Bloor, Adrian
Nicholson, E.
Eder, M.
Orchard, K. H.
Citations
Altmetric:
Abstract
Authors
Afonso, J. D.
Finke, J.
Ngoya, M.
Galimard, J. E.
Craddock, C.
Raj, K.
Bloor, Adrian
Nicholson, E.
Eder, M.
Orchard, K. H.
Valerius, T.
Snowden, J. A.
Tholouli, E.
Crawley, C.
Collin, M. P.
Wilson, K.
Gadisseur, A.
Protheroe, R. E.
Wagner, E. M.
Savani, B.
Spyridonidis, A.
Ciceri, F.
Nagler, A.
Mohty, M.
Finke, J.
Ngoya, M.
Galimard, J. E.
Craddock, C.
Raj, K.
Bloor, Adrian
Nicholson, E.
Eder, M.
Orchard, K. H.
Valerius, T.
Snowden, J. A.
Tholouli, E.
Crawley, C.
Collin, M. P.
Wilson, K.
Gadisseur, A.
Protheroe, R. E.
Wagner, E. M.
Savani, B.
Spyridonidis, A.
Ciceri, F.
Nagler, A.
Mohty, M.
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Afonso JD, Finke J, Ngoya M, Galimard JE, Craddock C, Raj K, et al. Comparison of Fludarabine/Melphalan (FluMel) with Fludarabine/Melphalan/BCNU or Thiotepa (FBM/FTM) in Patients with AML in First Complete Remission Undergoing Allogeneic Hematopoietic Stem Cell Transplantation - a Registry Study on Behalf of the EBMT Acute Leukemia Working Party. Blood. 2022 Nov;140:2110-2. PubMed PMID: WOS:000893223202046.